| Brief Counseling (N=126) |
PSF Intensive Group Therapy (N=120) |
P-value | |
|---|---|---|---|
| Age at Study Inclusion | |||
| Mean (SD) | 51 (± 9.1) | 50 (± 9.0) | 0.441 |
| Missing | 1 (0.8%) | 1 (0.8%) | |
| Gender | |||
| Male | 63 (50 %) | 63 (52 %) | 0.581 |
| Female | 60 (48 %) | 47 (39 %) | |
| Transgender | 2 (2 %) | 1 (1 %) | |
| Missing | 1 (0.8%) | 9 (7.5%) | |
| Race | |||
| Black | 75 (60 %) | 65 (54 %) | 0.77 |
| Declared none or multiple or other racial groups | 35 (28 %) | 30 (25 %) | |
| White | 12 (10 %) | 14 (12 %) | |
| Missing | 4 (3.2%) | 11 (9.2%) | |
| Ethnicity | |||
| Latinx | 22 (17 %) | 20 (17 %) | 1 |
| Non-Latinx | 102 (81 %) | 90 (75 %) | |
| Missing | 2 (1.6%) | 10 (8.3%) | |
| Education Level | |||
| Less than high school | 44 (35 %) | 45 (38 %) | 0.477 |
| More than high school | 81 (64 %) | 66 (55 %) | |
| Missing | 1 (0.8%) | 9 (7.5%) | |
| Housing Status | |||
| Stable | 100 (79 %) | 95 (79 %) | 0.338 |
| Transitional/Homeless | 25 (20 %) | 16 (13 %) | |
| Missing | 1 (0.8%) | 9 (7.5%) | |
| CD4 Count at Study Inclusion | |||
| Mean (SD) | 600 (± 350) | 620 (± 440) | 0.823 |
| Missing | 6 (4.8%) | 10 (8.3%) | |
| Mode of HIV Transmission | |||
| Injection drug use | 17 (13 %) | 8 (7 %) | 0.138 |
| Sexual contact with an HIV-infected partner of the opposite sex | 63 (50 %) | 73 (61 %) | |
| Sexual contact with an HIV-infected partner of the same sex | 29 (23 %) | 20 (17 %) | |
| Transfusion/Other | 13 (10 %) | 10 (8 %) | |
| Missing | 4 (3.2%) | 9 (7.5%) | |
| Age of First Tobacco Use | |||
| Mean (SD) | 17 (± 5.8) | 17 (± 5.3) | 0.638 |
| Missing | 1 (0.8%) | 10 (8.3%) | |
| Frequency of Tobacco Use | |||
| Everyday | 107 (85 %) | 84 (70 %) | 0.166 |
| Some days | 17 (13 %) | 23 (19 %) | |
| Missing | 2 (1.6%) | 13 (10.8%) | |
| Average Daily Tobacco Use | |||
| Mean (SD) | 10 (± 7.3) | 9.3 (± 7.2) | 0.289 |
| Missing | 2 (1.6%) | 10 (8.3%) | |
| Dual Tobacco Use | |||
| No | 101 (80 %) | 92 (77 %) | 0.692 |
| Yes | 24 (19 %) | 18 (15 %) | |
| Missing | 1 (0.8%) | 10 (8.3%) | |
| Other Substance Use Within Prior 30 Days | |||
| No | 58 (46 %) | 63 (52 %) | 0.181 |
| Yes | 65 (52 %) | 48 (40 %) | |
| Missing | 3 (2.4%) | 9 (7.5%) | |
| History of Hypertension | |||
| No | 83 (66 %) | 75 (62 %) | 0.94 |
| Yes | 40 (32 %) | 34 (28 %) | |
| Missing | 3 (2.4%) | 11 (9.2%) | |
| History of Myocardial Infarction | |||
| No | 120 (95 %) | 105 (88 %) | 0.871 |
| Yes | 3 (2 %) | 4 (3 %) | |
| Missing | 3 (2.4%) | 11 (9.2%) | |
| History of Stroke | |||
| No | 119 (94 %) | 106 (88 %) | 1 |
| Yes | 4 (3 %) | 3 (2 %) | |
| Missing | 3 (2.4%) | 11 (9.2%) | |
| History of COPD/Emphysema | |||
| No | 103 (82 %) | 101 (84 %) | 0.0601 |
| Yes | 20 (16 %) | 8 (7 %) | |
| Missing | 3 (2.4%) | 11 (9.2%) | |
| History of Hepatitis C | |||
| No | 86 (68 %) | 87 (72 %) | 0.115 |
| Yes | 37 (29 %) | 22 (18 %) | |
| Missing | 3 (2.4%) | 11 (9.2%) | |
| History of Cancer | |||
| No | 113 (90 %) | 102 (85 %) | 0.806 |
| Yes | 10 (8 %) | 7 (6 %) | |
| Missing | 3 (2.4%) | 11 (9.2%) |